Migraine Drug Moves One Step Closer to European Approval
A new drug that could help some migraine sufferers is one step closer to approval.
The European Medicines Agency has recommended granting a marketing authorisation for Emgality.
That will now be considered by the European Commission.
It is a preventative drug and is intended for use by those suffering at least 4 migraines a month.
Dublin MEP Brian Hayes says a final decision on approval for the drug could be just months away.